WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Chemo-Targeted Therapies, Antibodies ???? Cetuximab, Cytokines Response modifiers ???? ????, Gefitinib EGFR NSCLC, Cytokines Response modifiers ???? ????, SER/THR Kinase Inhibitors ???? Sorafenib tosylate, Others Not metab by liver Thalidomide, Bortezomib Inhibits proteasome Multiple Melanoma, Sorafenib tosylate Raf/MEK/ERK VEGFR Renal Cell hepatocellular malignant melanoma, B-cell NHL Toxicities Renal, Chemo-targeted therapies ???? Others, Sunitinib Broad spectrum Tyrosine Kinase imatinib resitant GIST, Breast Cancer Toxicities Diarrhea heaptitis, Tretinoin Differetation APL, Lapatinib ER+ EGFR+ HER2+ Breast Cancer, Ipilimunab enhances T-cell Melanoma, Others Oral ATRA Tretinoin, Colorectal Breast Toxicites Hemorrhage, SER/THR Kinase Inhibitors ???? Vemurafenib, Thalidomide angiogenesis inhib Multiple myeloma, Multiple myeloma Toxicity Cardio CNS Teratogen